Serum IL10, IL12 and circulating CD4 +CD25 high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients

International Journal of Oncology

Volumn 40, Issue 3, 2012, Pages 833-839

  Green, Victoria L ^a   Irune, Ekpemi ^a   Prasai, Amit ^a   Alhamarneh, Osama ^a   Greenman, John ^a   Stafford, Nicholas D ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Follow up; Head and neck squamous cell carcinoma; IL10; IL12; Regulatory T cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CD4+ CD25+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PARANASAL SINUS CANCER; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84857187863     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1259     Document Type: Article

References (29)

1. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. New Eng J Med 363: 24-35, 2010.
2. Young MR: Protective mechanisms of head and neck squamous cell carcinomas from immune assault. Head Neck 28: 462-470, 2006.
3. Whiteside TL: The tumour microenvironment and its role in promoting tumour growth. Oncogene 27: 5904-5912, 2008.
4. Sparano A, Lathers DM, Achille N, Petruzzelli GJ and Young MR: Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 31: 573-576, 2004. (Pubitemid 39446277)
5. Jebreel A, Mistry D, Loke D, et al: Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol 121: 246-252, 2007. (Pubitemid 46833125)
6. Melinceanu L, Sarafoleanu C, Lerescu L, Tucureanu C, Caraş I and Salageanu A: Impact of smoking on the immunological profile of patients with laryngeal carcinoma. J Med Life 2: 211-218, 2009.
7. Agarwal A, Agarwal U, Verma S, Mohanty NK and Saxena S: Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy. Immunopharmacol Immunotoxicol 32: 348-356, 2010.
8. LaCelle MG, Jensen SM and Fox BA: Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy. Clin Cancer Res 15: 6881-6890, 2009.
9. Sakaguchi S and Ohkura N: Regulatory T cells; roles of T cell receptor for their development and function. Semin Immunopathol 32: 95-106, 2010.
10. + regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500, 2010.
11. Boucek J, Mrkvan T, Chovanec M, et al: Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. J Cell Mol Med 14: 426-433, 2010.
12. Lau KM, Cheng SH, Lo KW, et al: Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer 96: 617-622, 2007.
13. Alhamarneh O, Agada F, Madden L, Stafford N and Greenman J: Serum IL10 and circulating CD4(+)CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck 33: 415-423, 2011.
14. Mosser DM and Zhang X: Intereukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218, 2008.
15. Bien E, Balcerska A, Adamkiewicz-Drozynska E, Rapala M, Krawczyk M and Stepinski J: Pre-treatment serum levels of interleukin- 10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Clin Biochem 42: 1144-1157, 2009.
16. Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T and Zembala M: Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res 29: 5005-5012, 2009.
17. Svobodova S, Topolcan O, Holubec L Jr, Levy M, Pecen L and Svacina S: Parameters of biological activity in colorectal cancer. Anticancer Res 31: 373-378, 2011.
18. Fuksiewicz M, Kowalska M, Kotowicz B, Rubach M, Chechlinska M, Pienkowski T and Kaminska J: Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer. Clin Chem Lab Med 48: 1481-1486, 2010.
19. Lathers DMR and Young MRI: Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 25: 220-228, 2004. (Pubitemid 38229413)
20. Günaydin RO, Kesikli SA, Kansu E and Hoşal AS: Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma. Head Neck doi: 10.1002/hed.21738. [Epub ahead of print], 2011.
21. Pulimood PV, Davies GR and Birchall MA: Interleukins 7 and 12 are expressed in head and neck squamous cancer. Clin Otolaryngol Allied Sci 26: 302-306, 2001. (Pubitemid 32955510)
22. Van Herpen CM, Looman M, Zonneveld M, et al: Intratumoural administration of recombinant human interleukin-12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodes. Clin Cancer Res 10: 2626-2635, 2004. (Pubitemid 38509135)
23. Westra WH: The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 3: 78-81, 2009.
24. http://seer.cancer.gov/csr/1975-2007/.
25. Chandler SW, Rassekh CH, Rodman SM and Ducatman BS: Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas. Laryngoscope 112: 808-815, 2002. (Pubitemid 34477609)
26. Schott AK, Pries R and Wollenberg B: Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med 26: 67-75, 2010.
27. Strauss L, Bergmann C, Gooding W, Johnson JT and Whiteside TL: The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13: 6301-6311, 2007. (Pubitemid 350075018)
28. Chikamatsu K, Sakakura K, Whiteside TL and Furuya N: Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck. Head Neck 29: 120-127, 2007. (Pubitemid 46167778)
29. Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O and Hashimoto K: Tumour infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 744-752, 2010.